Skip to Main Content
Try STAT+ TODAY
Trending:
Health
Biotech
Pharmalot
STAT+
Subscribe Now To access exclusive content, subscribe to STAT+
View Latest View the latest STAT+ stories
Live Chat
STAT+

Archive online chat: The week in biotech, JPM, and beyond

  • Adam Feuerstein
  • Rebecca Robbins
  • Matthew Herper

By Adam Feuerstein , Rebecca Robbins and Matthew Herper Jan. 11, 2019

Reprints

Couldn’t make it to this year’s J.P. Morgan Healthcare Conference? You made it but were left with questions? Join Adam Feuerstein, Rebecca Robbins, and Matt Herper for a live, subscriber-only chat about the latest in the industry and the highlights from the ground in San Francisco.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED

About the Authors Reprints

Adam Feuerstein

Adam Feuerstein

Senior Writer, Biotech

Adam Feuerstein is STAT’s national biotech columnist, reporting on the intersection of biotech and Wall Street. He's also a co-host of "The Readout LOUD" podcast.

Rebecca Robbins

Rebecca Robbins

Health Tech Correspondent

Rebecca covers health technology. She is the co-author of the newsletter STAT Health Tech.

Matthew Herper

Matthew Herper

Senior Writer, Medicine, Editorial Director of Events

Matthew Herper covers medical innovation — both its promise and its perils.

I was laid off from a public health job.…
I was laid off from a public health job. Trust me, tech layoffs are different
Medicare Advantage insurers will score $2 billion gift thanks…
Medicare Advantage insurers will score $2 billion gift thanks to limited audits
‘Microdosing’ is touted by ’shroomers and Reddit users. Science…
‘Microdosing’ is touted by ’shroomers and Reddit users. Science is starting to test their claims —…
KKR veteran sets records with $3.9 billion health care…
KKR veteran sets records with $3.9 billion health care fund
6 things to know about Apellis’ eye drug ahead…
6 things to know about Apellis’ eye drug ahead of FDA decision
Gene therapy can transform life for people with hemophilia.…
Gene therapy can transform life for people with hemophilia. But some patients don’t want it.

Recommended Stories